|
|
|
|
|
|
|
|
|
23. |
CASH FLOW INFORMATION |
|
|
|
|
CONSOLIDATED |
THE COMPANY |
|
|
2007 |
2006 |
2007 |
2006 |
|
|
R million |
R million |
R million |
R million |
|
23.1 Adjustments |
|
|
|
|
Depreciation, amortisation of goodwill and trade marks |
237 |
302 |
|
|
Movement in provisions |
(58) |
65 |
|
|
Interest received |
(334) |
(341) |
|
|
Finance cost |
30 |
29 |
|
|
Dividends received |
(156) |
(410) |
(3 358) |
(4 191) |
Capital surplus on the sale of investments |
(7) |
(3 161) |
|
|
Net impairment of assets |
|
(3) |
|
|
Share scheme cost |
18 |
18 |
|
|
Negative goodwill |
(44) |
|
|
|
Exchange rate gain/(loss) on foreign cash |
622 |
(85) |
|
|
Other |
1 |
(2) |
|
|
|
309 |
(3 588) |
(3 358) |
(4 191) |
23.2 Decrease/(increase) in working capital |
|
|
|
|
Decrease/(increase) in inventories and biological agricultural |
|
|
|
|
assets |
(180) |
(139) |
|
|
Decrease/(increase) in trade and other receivables |
(109) |
(121) |
(1) |
(4) |
Increase/(decrease) in trade and other payables |
86 |
252 |
3 |
2 |
Net movement in derivative instruments |
33 |
(33) |
|
|
|
(170) |
(41) |
2 |
(2) |
23.3 Reconciliation of dividends received |
|
|
|
|
Receivable at the beginning of the year |
|
129 |
|
|
Per income statement |
156 |
410 |
3 358 |
4 191 |
Dividends from associated companies set off against |
|
|
|
|
investments |
2 748 |
3 349 |
|
|
Receivable at the end of the year |
(168) |
|
|
|
Cash received |
2 736 |
3 888 |
3 358 |
4 191 |
23.4 Reconciliation of taxation paid with the amount |
|
|
|
|
disclosed in the income statement |
|
|
|
|
Paid in advance at the beginning of the year |
67 |
60 |
|
|
Unpaid at the beginning of the year |
(473) |
(69) |
|
|
Per income statement |
(360) |
(854) |
|
|
normal income |
(339) |
(491) |
|
|
capital gain |
|
(350) |
|
|
STC |
(21) |
(13) |
|
|
Medi-Clinic |
|
91 |
|
|
Business acquired |
|
(3) |
|
|
Unpaid at the end of the year |
104 |
473 |
|
|
Paid in advance at the end of the year |
(14) |
(67) |
|
|
Cash paid |
(676) |
(369) |
|
|
23.5 Reconciliation of dividends paid |
|
|
|
|
Per statements of changes in equity |
(3 748) |
(4 525) |
(3 782) |
(4 860) |
Paid by subsidiary companies to minority |
(65) |
(151) |
|
|
Cash paid |
(3 813) |
(4 676) |
(3 782) |
(4 860) |
|
|
|
|
|
|